Colorectal Cancer Trial, Recruiting NCT07546565 Sponsor: University Medical Center Ho Chi Minh City (UMC) Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07546565
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with colon cancer classified as stage I, II, or III (meaning the cancer has not spread to distant parts of the body)
  • People who are scheduled for a planned (non-emergency) surgical procedure to remove the right portion of the colon, performed using keyhole (laparoscopic) techniques at University Medical Center Ho Chi Minh City
  • People whose tissue sample taken after surgery confirms a specific type of colon cancer called adenocarcinoma

Who may not be able to join:

  • People who require emergency surgery rather than a planned operation
  • People for whom bowel preparation (cleaning out the bowel before surgery) is not medically safe, for example due to a blocked, perforated, or partially blocked bowel, or an abscess near the tumour
  • People for whom keyhole surgery or the specific internal joining technique used in this trial is not considered medically safe, including those assessed as having very severe overall health risks under a standard anaesthesia classification system (ASA level IV or V)
  • People whose cancer has already spread to distant parts of the body (stage IV)
  • People whose colon cancer has returned after a previous surgery
  • People who have another separate cancer present in a different organ at the same time
  • People who are having surgery aimed at relieving symptoms only (palliative surgery), or surgery to manage complications of the tumour, rather than surgery intended to remove the cancer completely
  • People who would be unlikely to complete follow-up appointments or be reachable for contact after the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tran D Huy, PhD, MD, University medical center HCMC

Phone: +84909873773

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Medical Center Ho Chi Minh City (UMC)
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
30 September 2027

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

Surgical Site Infection (SSI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov